iTeos Therapeutics, Inc. (ITOS)
10.15
+0.02 (0.20%)
Inactive · Last trade price on Aug 28, 2025
iTeos Therapeutics Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for iTeos Therapeutics stock had an average target of $10.4, with a low estimate of $8.00 and a high estimate of $12.
Price Target: $10.4 (+2.46%)
Analyst Consensus: Hold
Price Target
Analyst Ratings
The average analyst rating for iTeos Therapeutics stock from 6 stock analysts was "Hold". This means that analysts believed this stock was likely to perform similarly to the overall market.
Recommendation Trends
No data available
| Rating | Oct 2026 |
|---|---|
| Strong Buy | n/a |
| Buy | n/a |
| Hold | n/a |
| Sell | n/a |
| Strong Sell | n/a |
| Total | n/a |
Financial Forecast
Revenue This Year
n/a
from 35.00M
Revenue Next Year
6.88M
EPS This Year
-3.58
from -3.32
EPS Next Year
-2.08
from -3.58
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | 35.4M | |||
| Avg | n/a | 6.9M | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -2.98 | -0.33 | |||
| Avg | -3.58 | -2.08 | |||
| Low | -4.39 | -3.45 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |